[Federal Register Volume 76, Number 40 (Tuesday, March 1, 2011)]
[Notices]
[Pages 11212-11213]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-4436]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Meeting of the Uniform Formulary Beneficiary Advisory Panel
AGENCY: Department of Defense, Assistant Secretary of Defense (Health
Affairs).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: Under the provisions of the Federal Advisory Committee Act of
1972 (Title 5, United States Code (U.S.C.), Appendix, as amended) and
the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended)
the Department of Defense announces the following Federal Advisory
Committee Meeting of the Uniform Formulary Beneficiary Advisory Panel
(hereafter referred to as the Panel).
DATES: March 24, 2011, from 9 a.m.- 1 p.m.
ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW.,
Washington, DC 20004.
FOR FURTHER INFORMATION CONTACT: Lieutenant Colonel Stacia Spridgen,
Designated Federal Officer, Uniform Formulary Beneficiary Advisory
Panel, 4130 Stanley Road, Suite 208, Ft. Sam Houston, TX 78234-6102,
Telephone: (210) 295-1271, Fax: (210) 295-2789. E-mail Address:
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose of Meeting: The Panel will review and comment on
recommendations made to the Director, TRICARE Management Activity, by
the Pharmacy and Therapeutics Committee regarding the Uniform
Formulary.
Meeting Agenda:
1. Sign-In.
2. Welcome and Opening Remarks.
3. Public Citizen Comments.
4. Scheduled Therapeutic Class Reviews (Comments will follow each
agenda item).
a. Pancreatic Enzymes.
b. Inflammatory Bowel Syndrome (IBS)/Inflammatory Bowel Disease
(IBD).
c. Antilipidemics--Lip-2.
d. Designated Newly Approved Drugs in Already-Reviewed Classes.
e. Pertinent Utilization Management Issues.
f. Drugs Recommended for Non-Formulary Placement Due to Non-
Compliance with the National Defense Authorization Act for Fiscal Year
2008, Section 703.
5. Panel Discussions and Vote.
Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and
Title 41, Code of Federal Regulations (CFR), Section 102-3.140 through
102-3.165, and the availability of space this meeting is open to the
public. Seating is limited and will be provided only to the first 220
people signing-in. All persons must sign-in legibly.
Administrative Work Meeting: Prior to the public meeting, the Panel
will conduct an Administrative Work Meeting from 7:30 a.m. to 9 a.m. to
discuss administrative matters of the Panel. The Administrative Work
Meeting will be held at the Naval Heritage Center, 701 Pennsylvania
Avenue, NW., Washington, DC 20004. Pursuant to 41 CFR 102-3.160, the
Administrative Work Meeting will be closed to the public.
Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-3.140,
the public or interested organizations may submit written statements to
the membership of the Panel at any time or in response to the stated
agenda of a planned meeting. Written statements should be submitted to
the Panel's Designated Federal Officer (DFO). The DFO's contact
information can be obtained from the General Services Administration's
Federal Advisory Committee Act Database--https://www.fido.gov/facadatabase/public.asp.
Written statements that do not pertain to the scheduled meeting of
the Panel may be submitted at any time. However, if individual comments
pertain to a specific topic being discussed at a planned meeting, then
these statements must be submitted no later than five business days
prior to the meeting in question. The DFO will review all submitted
written statements and provide copies to all the committee members.
Public Comments: In addition to written statements, the Panel will
set aside one hour for individuals or interested groups to address the
Panel. To ensure consideration of their comments, individuals and
interested groups should submit written statements as outlined in this
notice; but if they still want to address the Panel, then they will be
afforded the opportunity to register to address the Panel. The Panel's
DFO will have a ``Sign-Up Roster'' available at the Panel meeting, for
registration on a first-come, first-serve basis. Those wishing to
address the Panel will be given no more than five minutes to present
their comments, and at the end of the one hour time period, no further
public comments will be accepted. Anyone who signs up to address the
Panel, but is unable to do so due to the time limitation, may submit
their comments in writing; however, they must
[[Page 11213]]
understand that their written comments may not be reviewed prior to the
Panel's deliberation. Accordingly, the Panel recommends that
individuals and interested groups consider submitting written
statements instead of addressing the Panel.
Dated: February 23, 2011.
Morgan F. Park,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2011-4436 Filed 2-28-11; 8:45 am]
BILLING CODE 5001-06-P